Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Triiodothyronine T3 in Adipose Thermogenesis
2026-09-12
Triiodothyronine (T3) provides a reversible, receptor-proximal probe for separating thyroid hormone signaling from SETD7-dependent control of white adipose browning. This workflow combines T3 dose–time testing with thermogenic gene expression, mitochondrial phenotyping, and epistasis experiments to strengthen metabolic disorder research.
-
DATCPT Nanocarriers for Orthotopic Pancreatic Cancer
2026-09-12
The ACS Nano study introduces DATCPT, a pH/reactive oxygen species-responsive nanocarrier that sequentially adapts its surface charge, remodels tumor stroma, and releases camptothecin in orthotopic pancreatic cancer. Its main contribution is a coordinated strategy for addressing circulation, extracellular matrix, tumor penetration, and metastatic barriers rather than treating each obstacle independently.
-
Vancomycin Hydrochloride in Translational Assays
2026-09-11
Vancomycin hydrochloride is a mechanistically defined glycopeptide antibacterial agent for Gram-positive susceptibility and resistance studies. This guide extends conventional assay advice by showing how antimicrobial controls can be interpreted alongside tissue-engineering endpoints and infection-model design.
-
Dexamethasone (DHAP): From Mechanism to Translation
2026-09-11
A translational framework for using Dexamethasone (DHAP) to connect glucocorticoid signaling, immune-cell state, neuroinflammation, stem cell biology, and genetically informed model selection.
-
Astrocyte Heterogeneity Across Space and Time
2026-09-10
Schroeder et al. developed a cross-species, cross-regional transcriptomic atlas showing that astrocyte identity is strongly patterned by brain location and continues to change after birth. The study combines single-nucleus RNA sequencing with expansion microscopy to connect molecular programs with regional morphology, providing a framework for interpreting astrocyte specialization in mouse and marmoset.
-
ASB3-MAVS Control of Antiviral Immunity
2026-09-10
The 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ligase that suppresses antiviral innate immunity by promoting K48-linked ubiquitination and proteasomal degradation of MAVS. Its cell and animal experiments connect ASB3 activity with reduced type I interferon signaling and greater susceptibility to influenza A virus, establishing ASB3 as a mechanistic regulator of the RIG-I-like receptor pathway.
-
MiR-3180, Lipid Metabolism, and HCC Progression
2026-09-09
Hong et al. identify miR-3180 as a regulator that restrains hepatocellular carcinoma by simultaneously limiting SCD1-associated fatty acid synthesis and CD36-mediated lipid uptake. The study combines patient-tissue analysis, molecular validation, cell-function assays, lipid measurements, and xenograft experiments to connect this regulatory axis with tumor growth, invasion, metastasis, and prognosis.
-
Pregnenolone Carbonitrile: Assay Design Guide
2026-09-09
Pregnenolone Carbonitrile is more than a rodent PXR agonist: it can serve as a calibration probe for disease-state pharmacokinetics, CYP3A regulation, and liver fibrosis assays. This guide connects PCN mechanism with practical experimental decisions informed by a recent MASH pharmacokinetic study.
-
SCH772984: An ERK1/2 Lens on Tumor Resistance
2026-09-08
SCH772984 is a selective ERK1/2 inhibitor that enables precise interrogation of MAPK signaling, tumor-cell fitness, and treatment resistance. This article connects its assay utility with the Ang II–HIF-1α–HILPDA findings in nasopharyngeal carcinoma while separating established evidence from testable hypotheses.
-
TDRD9 siRNA Nanoparticles in P. aeruginosa Lung Injury
2026-09-07
The reference study identifies TDRD9 as a suppressor of neutrophil cuproptosis and develops hyaluronic acid-coated peptide nanoparticles to deliver TDRD9 siRNA during Pseudomonas aeruginosa lung infection. Evidence from patient-derived neutrophils, mouse models, and human lung organoids links TDRD9 silencing to reduced neutrophil accumulation, bacterial burden, inflammation, and tissue injury through the PD-L1/CD80/p38 MAPK axis.
-
NHS-Biotin Workflows for Protein Labeling
2026-09-07
NHS-Biotin provides a practical route to stable amine-directed labeling for antibody assays, intracellular studies, and streptavidin-based purification. Its short spacer and irreversible amide chemistry also make it useful for quality control around engineered nanobody assemblies, including the peptidisc-assisted systems described in recent research.
-
SB203580 Workflow for p38 MAPK Inflammation Studies
2026-09-05
Build cleaner p38 MAPK experiments with SB203580, from soluble stock preparation to epithelial–neutrophil chemotaxis assays. The workflow connects pathway inhibition with inflammation, neuroprotection studies, and multidrug resistance reversal while highlighting concentration-dependent kinase selectivity and practical troubleshooting.
-
Pam3CSK4: A Calibrated TLR1/2 Inflammation Probe
2026-09-04
Pam3CSK4 is a defined TLR1/2 agonist for dissecting immune activation, allergic inflammation, and neuroimmune regulation. This article presents a causal assay framework that separates direct innate immune signaling from TRPV1-driven systemic anti-inflammatory reflexes.
-
Nerve-Driven HDAC1 Control in Axolotl Regeneration
2026-09-04
Wang and colleagues show that nerve-dependent HDAC1 expression is required for blastema formation and successful limb regeneration in axolotls. Their combination of pharmacological inhibition, denervation, and nerve-factor supplementation links neural signaling to epigenetic regulation at the wound epidermis, providing a mechanistic framework for studying regeneration.
-
Vancomycin hydrochloride: Assay Reliability Guide
2026-09-03
This scenario-driven guide explains how Vancomycin hydrochloride, SKU B1223, can support Gram-positive bacteria inhibition, bacterial susceptibility testing, and antibiotic resistance assay design without being misapplied as a direct mammalian-cell viability reagent. It connects documented solubility, storage, and infection-model information with practical controls for reproducible laboratory workflows.